A third dose of Moderna's booster vaccine resulted in a 37-fold increase in antibody protection aga…

The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…

The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks …

"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…

The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …

The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…

Year-to-date, shares of BioNTech, Moderna, and Pfizer have surged 357%, 275%, and 28%, respectively.

"To justify $200 billion in value, one has to assume 1 to 1.5 billion doses of COVID-19 vaccine eac…

Moderna, the almost 11 year old company that created a 95% effective pandemic ending vaccine in les…

Alexion Therapeutics, which is set to be acquired by AstraZeneca, will be replaced by Moderna in th…

The EU's drug regulator is looking at reports about skin rash and kidney problems.

The CDC's guidance to pause the use of J&J's COVID vaccine came following reports of 6 rare blood c…

Moderna and Johnson & Johnson's vaccines are approved for adults over 18, while the vaccine from Pf…

Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…

The company during its earnings call also announced the September departure of Tal Zaks, its chief …

The decline comes with Moderna's stock having surged 693% year-to-date through Monday's close.

Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses…

Moderna is awaiting FDA authorization after a panel of experts recommended the vaccine be approved …

Moderna stock jumped after the biotech company said its COVID-19 vaccine can likely protect against…